Nutritional modulation of metabolic inflammation

Biochemical Society Transactions

Volumn 45, Issue 4, 2017, Pages 979-985

  Kirwan, Anna M ^a   Lenighan, Yvonne M ^a   O’Reilly, Marcella E ^a   McGillicuddy, Fiona C ^a   Roche, Helen M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; NLRP3 PROTEIN, HUMAN;

ADIPOCYTE; ANIMAL; ATHEROSCLEROSIS; BIOLOGICAL MODEL; DIET; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INSULIN RESISTANCE; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY;

ADIPOCYTES; ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIET; GENE EXPRESSION REGULATION; HUMANS; INFLAMMASOMES; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MACROPHAGES; MODELS, IMMUNOLOGICAL; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; OBESITY;

EID: 85027495934     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20160465     Document Type: Review

References (48)

1. Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature 444, 860–867 doi:10.1038/nature05485
2. McGillicuddy, F.C., de la Llera Moya, M., Hinkle, C.C., Joshi, M.R., Chiquoine, E.H., Billheimer, J.T. et al. (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119, 1135–1145 doi:10.1161/CIRCULATIONAHA.108.810721
3. James, W.P.T. (2008) WHO recognition of the global obesity epidemic. Int. J. Obes. 32, S120–S126 doi:10.1038/ijo.2008.247
4. Yu, B.-L., Zhao, S.-P. and Hu, J.-R. (2010) Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity. Obes. Rev. 11, 560–567 doi:10.1111/j.1467-789X.2009.00699.x
5. Crewe, C., An, Y.A. and Scherer, P.E. (2017) The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J. Clin. Invest. 127, 74–82 doi:10.1172/JCI88883
6. Berg, A.H. and Scherer, P.E. (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939–949 doi:10.1161/01.RES. 0000163635.62927.34
7. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante, A.W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 doi:10.1172/JCI19246
8. Kelly, B. and O’Neill, L.A.J. (2015) Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771–784 doi:10.1038/cr.2015.68
9. Kratz, M., Coats, B.R., Hisert, K.B., Hagman, D., Mutskov, V., Peris, E. et al. (2014) Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 20, 614–625 doi:10.1016/j.cmet.2014.08.010
10. Spiegelman, B.M. (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507–514 PMID:9568680
11. Huang, S., Rutkowsky, J.M., Snodgrass, R.G., Ono-Moore, K.D., Schneider, D.A., Newman, J.W. et al. (2012) Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 53, 2002–2013 doi:10.1194/jlr.D029546
12. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M.T.-H. et al. (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408–415 doi:10.1038/ni.2022
13. Mills, K.H.G. and Dunne, A. (2009) Immune modulation: IL-1, master mediator or initiator of inflammation. Nat. Med. 15, 1363–1364 doi:10.1038/ nm1209-1363
14. Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L. et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179–188 doi:10.1038/nm.2279
15. Hawley, S.A., Fullerton, M.D., Ross, F.A., Schertzer, J.D., Chevtzoff, C., Walker, K.J. et al. (2012) The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336, 918–922 doi:10.1126/science.1215327
16. Hardie, D.G. (2011) AMP-activated protein kinase—an energy sensor that regulates all aspects of cell function. Genes Dev. 25, 1895–1908 doi:10.1101/gad.17420111
17. Finucane, O.M., Lyons, C.L., Murphy, A.M., Reynolds, C.M., Klinger, R., Healy, N.P. et al. (2015) Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome–mediated IL-1β secretion and insulin resistance despite obesity. Diabetes 64, 2116–2128 doi:10.2337/db14-1098
18. Healy, N.P., Kirwan, A.M., McArdle, M.A., Holohan, K., Nongonierma, A.B., Keane, D. et al. (2016) A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling. Mol. Nutr. Food Res. 60, 2421–2432 doi:10.1002/mnfr.201501054
19. Lyons, C.L., Kennedy, E.B. and Roche, H.M. (2016) Metabolic inflammation-differential modulation by dietary constituents. Nutrients 8, 247 doi:10. 3390/nu8050247
20. Serhan, C.N., Chiang, N. and Van Dyke, T.E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349–361 doi:10.1038/nri2294
21. Bannenberg, G.L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K.H. et al. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345–4355 PMID:15778399
22. Oliver, E., McGillicuddy, F.C., Harford, K.A., Reynolds, C.M., Phillips, C.M., Ferguson, J.F. et al. (2012) Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J. Nutr. Biochem. 23, 1192–1200 doi:10.1016/j.jnutbio.2011.06.014
23. Börgeson, E., Docherty, N.G., Murphy, M., Rodgers, K., Ryan, A., O’Sullivan, T.P. et al. (2011) Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis. FASEB J. 25, 2967–2979 doi:10.1096/fj.11-185017
24. González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E. et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946–1957 doi: 10.1096/fj.08-125674
25. Phelan, N., O’Connor, A., Tun, T.K., Correia, N., Boran, G., Roche, H.M. et al. (2011) Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 93, 652–662 doi:10.3945/ajcn.110.005538
26. Itariu, B.K., Zeyda, M., Hochbrugger, E.E., Neuhofer, A., Prager, G., Schindler, K. et al. (2012) Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am. J. Clin. Nutr. 96, 1137–1149 doi:10.3945/ajcn.112.037432
27. Micallef, M.A. and Garg, M.L. (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476–482 doi:10.1016/j.atherosclerosis.2008.09.020
28. Skulas-Ray, A.C., Kris-Etherton, P.M., Harris, W.S., Vanden Heuvel, J.P., Wagner, P.R. and West, S.G. (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am. J. Clin. Nutr. 93, 243–252 doi:10.3945/ajcn.110.003871
29. Kiecolt-Glaser, J.K., Belury, M.A., Andridge, R., Malarkey, W.B., Hwang, B.S. and Glaser, R. (2012) Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav. Immun. 26, 988–995 doi:10.1016/j.bbi.2012.05.011
30. Zhao, G., Etherton, T.D., Martin, K.R., West, S.G., Gillies, P.J. and Kris-Etherton, P.M. (2004) Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 134, 2991–2997 PMID:15514264
31. Tricon, S., Burdge, G.C., Jones, E.L., Russell, J.J., El-Khazen, S., Moretti, E. et al. (2006) Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am. J. Clin. Nutr. 83, 744–753 PMID:16600923
32. Kien, C.L., Bunn, J.Y., Fukagawa, N.K., Anathy, V., Matthews, D.E., Crain, K.I. et al. (2015) Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes. J. Nutr. Biochem. 26, 1599–1606 doi:10.1016/j.jnutbio.2015.07.014
33. Tierney, A.C., McMonagle, J., Shaw, D.I., Gulseth, H.L., Helal, O., Saris, W.H.M. et al. (2011) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a european randomized dietary intervention study. Int. J. Obes 35, 800–809 doi:10.1038/ ijo.2010.209
34. Forouhi, N.G., Koulman, A., Sharp, S.J., Imamura, F., Kröger, J., Schulze, M.B. et al. (2014) Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2, 810–818 doi:10.1016/S2213-8587(14)70146-9
35. Forouhi, N.G. (2015) Association between consumption of dairy products and incident type 2 diabetes—insights from the european prospective investigation into cancer study. Nutr. Rev. 73(Suppl 1), 15–22 doi:10.1093/nutrit/nuv018
36. de Luca, C. and Olefsky, J.M. (2008) Inflammation and insulin resistance. FEBS Lett. 582, 97–105 doi:10.1016/j.febslet.2007.11.057
37. Lee, J.S., Pinnamaneni, S.K., Eo, S.J., Cho, I.H., Pyo, J.H., Kim, C.K. et al. (2006) Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J. Appl. Physiol. 100, 1467–1474 doi:10.1152/japplphysiol.01438.2005
38. Reynolds, C.M., McGillicuddy, F.C., Harford, K.A., Finucane, O.M., Mills, K.H.G., Roche, H.M. et al. (2012) Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells—implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 56, 1212–1222 doi:10.1002/mnfr. 201200058
39. Savage, D.B., Petersen, K.F. and Shulman, G.I. (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507–520 doi:10.1152/physrev.00024.2006
40. El-Assaad, W., Buteau, J., Peyot, M.-L., Nolan, C., Roduit, R., Hardy, S. et al. (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology 144, 4154–4163 doi:10.1210/en.2003-0410
41. Rader, D.J. (2003) Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 92, 42J–49J PMID:12957326
42. Khera, A.V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M.F., Jafri, K. et al. (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364, 127–135 doi:10.1056/NEJMoa1001689
43. O’Reilly, M., Dillon, E., Guo, W., Finucane, O., McMorrow, A., Murphy, A. et al. (2016) High-density lipoprotein proteomic composition, and not efflux capacity, reflects differential modulation of reverse cholesterol transport by saturated and monounsaturated Fat diets. Circulation 133, 1838–1850 doi:10.1161/CIRCULATIONAHA.115.020278
44. Nishimoto, T., Pellizzon, M.A., Aihara, M., Stylianou, I.M., Billheimer, J.T., Rothblat, G. et al. (2009) Fish oil promotes macrophage reverse cholesterol transport in mice. Arterioscler. Thromb. Vasc. Biol. 29, 1502–1508 doi:10.1161/ATVBAHA.109.187252
45. Kasbi Chadli, F., Nazih, H., Krempf, M., Nguyen, P. and Ouguerram, K. (2013) Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet. PLoS ONE 8, e61109 doi:10.1371/journal.pone.0061109
46. Ruffino, J.S., Davies, N.A., Morris, K., Ludgate, M., Zhang, L., Webb, R. et al. (2016) Moderate-intensity exercise alters markers of alternative activation in circulating monocytes in females: a putative role for PPARγ. Eur. J. Appl. Physiol. 116, 1671–1682 doi:10.1007/s00421-016-3414-y
47. Youm, Y.-H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D. et al. (2015) The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263–269 doi:10.1038/nm.3804
48. Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S.C. et al. (2016) Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 23, 591–601 doi:10.1016/j.cmet.2016.02.005